Is a superficially invasive squamous cell carcinoma (SCC) considered aggressive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Superficially Invasive Squamous Cell Carcinoma: Aggressiveness Assessment

Superficially invasive squamous cell carcinoma (SISCCA) is considered a non-aggressive form of squamous cell carcinoma with low metastatic potential. 1

Definition and Classification

  • SISCCA is defined as anal cancer that has been completely excised, with ≤3-mm basement membrane invasion and a maximal horizontal spread of ≤7 mm (T1, NX) 1
  • It is typically found incidentally during biopsy or excision of what was thought to be a benign lesion such as a condyloma, hemorrhoid, or anal skin tag 1
  • SISCCA falls into the low-risk category of squamous cell carcinomas, with a metastatic rate of ≤2% 2

Risk Assessment

Low-Risk Features of SISCCA

  • Superficial invasion (≤3mm depth) 1
  • Limited horizontal spread (≤7mm) 1
  • Well-differentiated histology 1
  • No perineural involvement 1
  • No lymphovascular invasion 3

Factors That Would Increase Risk

While SISCCA itself is non-aggressive, certain factors would increase the risk profile:

  • Perineural involvement (significantly increases risk of recurrence and metastasis) 1
  • Poor differentiation (associated with worse outcomes) 1
  • Desmoplastic features (associated with increased risk of recurrence and metastasis) 1
  • Invasion into deep reticular dermis or subcutaneous fat 1
  • Immunosuppression (particularly HIV infection can lead to more aggressive behavior) 4
  • Location in high-risk anatomic sites 5

Management Implications

  • For SISCCA with histologically negative margins in carefully selected patients, local excision alone with a structured surveillance plan may represent adequate treatment 1
  • A careful surveillance plan is necessary as observational studies have reported detection of high-grade squamous intraepithelial lesions in 74% of patients after local excision 1
  • For lesions with higher risk features, more aggressive treatment approaches may be warranted 3, 5

Clinical Outcomes

  • A retrospective study of patients with completely excised invasive anal cancer, including those meeting criteria for superficially invasive disease, showed excellent outcomes with 5-year overall survival of 100% and 5-year cancer recurrence-free survival rates of 87% 1
  • This supports the classification of SISCCA as a non-aggressive variant of squamous cell carcinoma 1, 2

Important Considerations

  • Although the risk of metastasis from SISCCA is negligible, the risk of recurrence depends on the presence or absence of additional risk factors 1
  • Regular follow-up is essential as these lesions can recur locally 1
  • The NCCN guidelines specifically categorize superficial basal cell carcinoma as non-aggressive, and the same principle applies to superficially invasive SCC 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.